Bio-Rad Laboratories, Inc. (BIO.B) vs STERIS plc (STE)
Bio-Rad Laboratories, Inc. and STERIS plc are both Medical Devices companies. STERIS plc is the larger, with a market value of $20.4B against $10.3B — 2.0× the size. STERIS plc trades at the lower P/E: 25.4× against 43.8×. STERIS plc grew revenue faster over the last twelve months: 8.37% against 1.37%. STERIS plc has the higher net margin (13.3% vs 8.59%) and the higher return on invested capital (8.27% vs 0.49%). Across the 22 metrics below, STERIS plc leads on 15 and Bio-Rad Laboratories, Inc. on 7.
Valuation
Profitability
| Metric | BIO.B | STE | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.90% | 44.43% | 56.01% |
| Operating margin | 2.05% | 18.91% | (15.03%) |
| Net margin | 8.59% | 13.33% | (20.40%) |
| Free cash flow margin | 13.64% | 15.50% | (7.24%) |
| Return on equity | 3.11% | 11.35% | (15.32%) |
| Return on assets | 2.17% | 7.62% | (19.72%) |
| Return on invested capital | 0.49% | 8.27% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack